U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday.
The Dow traded up 0.88% to 35,742.35 while the NASDAQ fell 0.79% to 14,145.17. The S&P 500 also fell, dropping, 0.15% to 4,543.88.
The deal with Novartis seeks to advance Legend Biotech's autologous CAR-T cell therapy candidate, LB2102, and other potential CAR-T cell therapies targeting Delta-like ligand protein 3 (DLL3), using the Novartis